Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of HIV Vaccine 732461 in Healthy Adults
NCT00434512Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2007
- Primary completion
- Jun 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GSK732461 in human immunodeficiency virus infection (HIV), sponsored by GSK. Started Feb 2007; status: completed.
02
Drugs
GSK732461
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00434512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434512.